Skip to main content

Inspection visit

Health inspection

WINDSOR THE RIDGE REHABILITATION CENTERCMS #5550601 citation on this visit
1 citation recorded

Inspector’s narrative

What the inspector wrote

This survey cited 1 deficiency. The full statement and the facility’s plan of correction follow, verbatim from the federal record.

F 0758 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Few Implement gradual dose reductions(GDR) and non-pharmacological interventions, unless contraindicated, prior to initiating or instead of continuing psychotropic medication; and PRN orders for psychotropic medications are only used when the medication is necessary and PRN use is limited. **NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on interview and record review, the facility failed to monitor for side effects of psychotropic medication (medication given to cause changes in mood, feelings or behavior) for one of three sample residents (Resident 1). The facility also failed to obtain informed consent before administering psychotropic medication to Resident 1. Failure to monitor for psychotropic medicaion side effects had the potential to compromise Resident 1's health. Failure to obtain informed consent had the potential to compromise Resident 1's ability to make informed decisions regarding his treatment. Findings: 1. Review of Resident 1's medical record indicated he was admitted on [DATE] and had the diagnosis of bipolar disorder (a mental health condition that causes extreme mood swings). Review of Resident 1's Order Summary Report indicated he had a physician's order, dated 11/23/22, for divalproex sodium (a seizure medication often used as a mood stabilizer) 250 milligrams (mg, unit of dose measurement) one tablet by mouth at bedtime for bipolar disorder. Review of Resident 1's medicaion administration record (MAR) indicated he was receiving divalproex sodium 250 mg at bedtime for bipolar disorder from 11/23/22 until 3/14/23 (except when he refused the medication). Further review of the medical record indicated there was no documentation that the facility monitored Resident 1 for side effects of divalproex sodium. During an interview and concurrent record review with the director of nursing (DON) on 5/10/23 at 11:42 a.m., she stated for residents taking psychotropic medication, the nurses should monitor for side effects every shift and document this on the MAR. The DON reviewed Resident 1's medical record and confirmed there was no documentation that the nurses monitored him for side effects of divalproex sodium. Review of the facility's policy titled Psychotropic Medication Management, revised 10/24/17 indicated, Medication effects will be monitored and documented on the medication administration record, to include target behavior monitoring, and monitoring for adverse effects when the medications are used. 2. Review of Resident 1's Order Summary Report indicated he had a physician's order, dated 10/15/22, for lorazepam (medication used to treat anxiety) 0.5 mg one tablet by mouth every 6 hours as needed for anxiety. (continued on next page) Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation. LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER REPRESENTATIVE'S SIGNATURE TITLE (X6) DATE FORM CMS-2567 (02/99) Previous Versions Obsolete Facility ID: If continuation sheet Page 1 of 2 Event ID: 555060 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 555060 B. Wing A. Building (X3) DATE SURVEY COMPLETED 05/10/2023 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Windsor the Ridge Rehabilitation Center 350 Iris Drive Salinas, CA 93906 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0758 Level of Harm - Minimal harm or potential for actual harm Review of Resident 1's MAR, dated 10/2022, indicated he received lorazepam 0.5 mg on 10/16/22, 10/18/22, and 10/20/22. Resident 1's Facility Verification of Informed Consent for lorazepam was reviewed. The document was signed and dated 10/24/22 (8 days after Resident 1 received the first dose of lorazepam). Residents Affected - Few During an interview and concurrent record review with the medical records director (MRD) on 5/8/23 at 1:27 p.m., she reviewed Resident 1's electronic health record (EHR) and confirmed the Verification of Informed Consent for lorazepam was dated 10/24/22. The MRD searched Resident 1's EHR and paper chart and confirmed there was no other Facility Verification of Informed Consent for lorazepam. During an interview and concurrent record review with the DON on 5/10/22 at 11:40 a.m., she confirmed the facility must obtain informed consent prior to administering psychotropic medication. The DON reviewed Resident 1's MAR an acknowledged he received lorazepam on 10/16/22, 10/18/22, and 10/20/22. The DON reviewed Resident 1's Verification of Informed Consent for lorazepam and confirmed it was dated 10/24/22. She searched Resident 1's medical record and confirmed there was no Verification of Informed Consent for lorazepam prior to 10/24/22. Review of the facility's policy titled Psychotropic Medication Management, revised 10/24/17 indicated, Informed consent for the use of psychoactive medication must be contained in the clinical record. FORM CMS-2567 (02/99) Previous Versions Obsolete Event ID: Facility ID: 555060 If continuation sheet Page 2 of 2

Reading this as a family member? Your long-term care ombudsman is a free advocate for residents and families.

Back to top

Citations

1 citation recorded*CMS

What do CMS severity letters mean?

Serious (G-L). Actual harm to a resident, or immediate jeopardy. Codes G through I indicate actual harm; J through L indicate immediate jeopardy to resident health or safety.

General (A-F). No actual harm found, or harm that is minimal. The facility must still submit a Plan of Correction. Most CMS citations land here.

Each letter combines severity with scope: how many residents the deficiency affected.

  • 0758GeneralS&S Dpotential for harm

    F758 - Medication Errors

    Implement gradual dose reductions(GDR) and non-pharmacological interventions, unless contraindicated, prior to initiating or instead of continuing psychotropic medication; and PRN orders for psychotropic medications are only used when the medication is necessary and PRN use is limited.

FAQ · About this visit

Common questions about this visit

What happened during the May 10, 2023 survey of WINDSOR THE RIDGE REHABILITATION CENTER?

This was a inspection survey of WINDSOR THE RIDGE REHABILITATION CENTER on May 10, 2023. The surveyor cited 1 deficiency, recorded on the federal Form 2567 statement of deficiencies.

Were any deficiencies cited at WINDSOR THE RIDGE REHABILITATION CENTER on May 10, 2023?

Yes, 1 deficiency was cited, each with a CMS Scope and Severity grade. The first was: "Implement gradual dose reductions(GDR) and non-pharmacological interventions, unless contraindicated, prior to initiatin..."

What type of survey was this?

This was a inspection survey conducted by state surveyors under federal Centers for Medicare & Medicaid Services (CMS) oversight. Findings are published on CMS Care Compare.

Share this reportEmail

Next steps

Concerned about a resident’s care?Find your local ombudsman through the Eldercare Locatoror file a complaint with your state survey agency.

Researching this visit professionally?Book a 15-minute calland we will walk through what we have on file.

Data from CMS Care Compare public records. Dataset last refreshed . If you believe any information is inaccurate, report it here.